NPS Pharmaceuticals (NPSP) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Total operating expenses: 52.67M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Total operating expenses: 52.67M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
NPS Pharmaceuticals (NASDAQ: NPSP) reported Q3 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $59.5 million.
For earnings history and earnings-related data on NPS Pharmaceuticals (NPSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
